Aging Clinical Trial
— ECEOfficial title:
The Entorhinal Cortex and Aerobic Exercise in Aging
Verified date | May 2023 |
Source | Boston University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The overall goal of this study is to examine how regular exercise affects brain function, spatial memory, and virtual navigation. Participation in this research study will take approximately 4 months.
Status | Terminated |
Enrollment | 29 |
Est. completion date | February 9, 2021 |
Est. primary completion date | February 9, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 80 Years |
Eligibility | Inclusion Criteria: - Age between 60-80 years - Physical inactivity/sedentary status (The American College of Sports Medicine defines a sedentary lifestyle as a lifestyle in which a person is not participating in at least 30 minutes of moderate intensity physical activity on at least three days per week for at least three months.) - Generally healthy - Living in the greater Boston area - Fluent in English (must have attended elementary school and higher in English) - Non-smoking Exclusion Criteria: - Poor vision that cannot be corrected with glasses or contact lenses - Presence of an acute infection - Diagnosis of kidney failure - Diagnosis of liver disease - Diagnosis of thyrotoxicosis/hyperthyroidism - Diagnosis of cancer - Diagnosis of severe anemia - Past or present conditions that affect cognitive functioning: - learning disability - neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.) - psychiatric disorders or conditions within last 5 years (depression, anxiety disorder, etc.) - Severe stress - Evidence of cognitive impairment (e.g. dementia) - Claustrophobia (fear of small, enclosed spaces) - Obesity - Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and physical exercise: - heart conditions (e.g. heart attack, arrhythmias, etc.) - circulatory conditions (e.g. uncontrolled hypertension, leg claudication, high cholesterol, etc.) - respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.) - current musculoskeletal impairments (e.g. fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.) - diagnosis of electrolyte disorder or abnormality - presence of diabetes mellitus - Prescription medication or other drugs that treat heart, lung, or circulatory conditions (e.g. beta blockers, bronchodilators, etc.) - Prescription medication or other drugs that affect chemicals in the brain (e.g. antidepressants, anxiolytics, etc.) - Drug abuse or alcohol misuse - Metal in or on the body that cannot be removed (e.g. pacemaker, defibrillator, metal implant that is ferrous) - Some known abnormal MRI findings (case by case basis) - Regularly exercising - Unavailable for the approx. 4-month duration of the study |
Country | Name | City | State |
---|---|---|---|
United States | Boston University School of Medicine | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Boston University | Brigham and Women's Hospital, Georgia Institute of Technology, National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional MRI - Right Subiculum | The fMRI is measuring blood oxygenation levels and blood flow in different regions of the brain and using that to determine activity changes in the brain. This measurement was obtained while participants were performing a virtual navigation task in the MRI scanner.
Data reported for fMRI is in beta-weight for navigation greater control contrast of BOLD images. The beta-weight is a standardized regression coefficient. Higher beta-weights mean greater activation and lower beta-weights mean less activation in specific brain regions being monitored. Negative beta-weights mean lower activation for the navigation condition than for the control condition, positive beta-weights mean greater activation for the navigation condition than for the control condition. |
0 months-baseline (pre-intervention) | |
Primary | Structural MRI - Right Dentate Gyrus Head | Measurement of regional brain volumes in the medial temporal lobes to assess change in regional brain volumes. Reported outcome measure is volume of the right anterior (i.e., head) dentate gyrus, a hippocampal subfield known to show plasticity in response to exercise in animal models. The hippocampus is part of the medial temporal lobes. | 0 months-baseline (pre-intervention) | |
Primary | Cognitive Test Performance: Spatial Memory | Participants will perform a spatial memory test during functional MRI. Measurements include baseline-to-follow-up change test performance. | 4 months | |
Primary | Cognitive Test Performance: Virtual Navigation | Participants will perform a virtual navigation test during functional MRI. Measurements include baseline-to-follow-up change in test performance. | 4 months | |
Primary | Functional MRI - Post-intervention Right Subiculum | The fMRI is measuring blood oxygenation levels and blood flow in different regions of the brain and using that to determine activity changes in the brain. This measurement was obtained while participants were performing a virtual navigation task in the MRI scanner.
Data reported for fMRI is in beta-weight for navigation greater control contrast of BOLD images. The beta-weight is a standardized regression coefficient. Higher beta-weights mean greater activation and lower beta-weights mean less activation in specific brain regions being monitored. Negative beta-weights mean lower activation for the navigation condition than for the control condition, positive beta-weights mean greater activation for the navigation condition than for the control condition. |
4 months | |
Primary | Structural MRI - Post-intervention Right Dentate Gyrus Head | Measurement of regional brain volumes in the medial temporal lobes to assess change in regional brain volumes. Reported outcome measure is volume of the right anterior (i.e., head) dentate gyrus, a hippocampal subfield known to show plasticity in response to exercise in animal models. The hippocampus is part of the medial temporal lobes. | 4 months | |
Secondary | Aerobic Capacity | Participants will perform a treadmill test to estimate baseline-to-follow-up change in aerobic capacity. Aerobic capacity is the maximum amount of oxygen (O2;(expressed in volume: VO2) a person can utilize during strenuous exercise. This maximum volume of oxygen is known as VO2max or aerobic capacity. For this study, we measured heart rate during the treadmill test and estimated VO2max from heart rate, thus we estimated VO2max rather than measured oxygen and carbondioxyde in the breath while exercising. VO2max is expressed in milliliters per kilogram of body weight per minute (ml/kg/min). We calculated percentage change from baseline to post-intervention. | 4 months | |
Secondary | Muscle Strength | Participants will perform several muscle strength tests to estimate baseline-to-follow-up change in muscle strength. Percentage change in chess press weight lifted is reported in results. | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |